Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Nov 2011

Kim Si-Hyun, Yim Dong-Seok, Choi Su-Mi, Kwon Jae-Cheol, Han Seunghoon, Lee Dong-Gun, Park Chulmin, Kwon Eun-Young, Park Sun Hee, Choi Jung-Hyun, Yoo Jin-Hong

Abstract excerpt

BACKGROUND: Voriconazole is a triazole agent with excellent antifungal activity against Aspergillus species. However, despite its potential advantages, the occurrence of unpredictable toxicities might be critical in immunocompromised patients. The aim of this study was to analyze risk factors for voriconazole-related severe adverse events (SAEs). METHODS: This prospective observational study was conducted in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspergillosis
Share to Aspergillus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Hematologic Neoplasms

Share to Immunocompromised Host

Share to Infusions, Intravenous

Share to Triazoles

Share to Voriconazole

Source

Identifiers

PMID: 21831685
DOI: 10.1016/j.ijid.2011.06.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.PMID 21831685Read ↗

CYP2C19-Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients.Semantic proximity Read ↗

Therapeutic drug monitoring of voriconazole.Semantic proximity Read ↗

Dual toxicity of voriconazole in a CYP2C19 poor metabolizer: A case analysis of Life-threatening neutropenia and hepatocellular injurySemantic proximity Read ↗

Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.Semantic proximity Read ↗

[CYP2C19 genetic polymorphism and monitoring voriconazole plasma concentrations in the treatment and prevention of invasive fungal disease for hematological patients].Semantic proximity Read ↗

Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Semantic proximity Read ↗

Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.Semantic proximity Read ↗

Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.Semantic proximity Read ↗

Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.Semantic proximity Read ↗

Population pharmacokinetics of voriconazole and CYP2C19 phenotype for dose optimization in hematological patients with invasive fungal infectionsSemantic proximity Read ↗

Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review.Semantic proximity Read ↗

Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.